DHL Expands Healthcare Capabilities with Acquisition of SDS Rx, Pending Regulatory Approvals

Reuters
09/09
DHL Expands Healthcare Capabilities with Acquisition of SDS Rx, Pending Regulatory Approvals

Deutsche Post AG's DHL Supply Chain has announced an agreement to acquire SDS Rx, a move set to expand its capabilities in life sciences and healthcare logistics. This strategic acquisition will enhance DHL's healthcare logistics portfolio, particularly in delivering integrated, time-critical solutions across the life sciences and healthcare supply chain. With SDS Rx's expertise in processing specialized healthcare deliveries and final-mile logistics services, DHL aims to strengthen its service offerings in long-term care, specialty pharmacies, radiopharmacies, and health system networks. This marks DHL's second healthcare acquisition in 2025, following its earlier purchase of CryoPDP, and aligns with its Strategy 2030 growth agenda.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Deutsche Post AG published the original content used to generate this news brief on September 09, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10